We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
1201
Tvardi Therapeutics
TVRD
$19.7M
$383K ﹤0.01%
556
-972
-64% -$494K
VIVS
1202
VivoSim Labs
VIVS
$1.2M
$383K ﹤0.01%
1,140
-683
-37% -$225K
CVRS
1203
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$379K ﹤0.01%
458,683
ACU icon
1204
Acme United Corp
ACU
$217M
$378K ﹤0.01%
18,205
FGBI icon
1205
First Guaranty Bancshares
FGBI
$159M
$375K ﹤0.01%
17,435
OCGN icon
1206
Ocugen
OCGN
$416M
$375K ﹤0.01%
2,500
ELON
1207
DELISTED
Echelon Corp
ELON
$374K ﹤0.01%
45,358
MCF
1208
DELISTED
Contango Oil & Gas Co.
MCF
$373K ﹤0.01%
65,600
RNGR icon
1209
Ranger Energy Services
RNGR
$376M
$372K ﹤0.01%
+40,600
New +$345K
UE icon
1210
Urban Edge Properties
UE
$2.86B
$370K ﹤0.01%
16,199
IMDZ
1211
DELISTED
Immune Design Corp.
IMDZ
$370K ﹤0.01%
81,292
-88,708
-52% -$353K
WTT
1212
DELISTED
Wireless Telecom Group, Inc.
WTT
$366K ﹤0.01%
166,300
BLCM
1213
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$365K ﹤0.01%
4,950
TPST icon
1214
Tempest Therapeutics
TPST
$13.7M
$363K ﹤0.01%
137
RMCF icon
1215
Rocky Mountain Chocolate Factory
RMCF
$7.93M
$362K ﹤0.01%
31,600
SSBI icon
1216
Summit State Bank
SSBI
$83.8M
$362K ﹤0.01%
25,795
WSTL
1217
DELISTED
Westell Technologies Inc
WSTL
$359K ﹤0.01%
126,000
SNDX icon
1218
Syndax Pharmaceuticals
SNDX
$1.69B
$355K ﹤0.01%
50,500
MN
1219
DELISTED
MANNING & NAPIER, INC.
MN
$355K ﹤0.01%
+114,500
New +$370K
DHX icon
1220
DHI Group
DHX
$182M
$353K ﹤0.01%
150,100
+112,300
+297% +$227K
QADB
1221
DELISTED
QAD Inc. Class B
QADB
$352K ﹤0.01%
8,700
LCNB icon
1222
LCNB Corp
LCNB
$282M
$349K ﹤0.01%
+17,700
New +$340K
INOD icon
1223
Innodata
INOD
$2.05B
$348K ﹤0.01%
348,455
GEG icon
1224
Great Elm Group
GEG
$67.4M
$346K ﹤0.01%
+96,219
New +$364K
RNTX
1225
Rein Therapeutics
RNTX
$63.1M
$345K ﹤0.01%
+3,180
New +$360K

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.